Cargando…

Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials

Delaying disease progression and reducing the risk of mortality are key goals in the treatment of chronic kidney disease (CKD). New drug classes to augment renin–angiotensin–aldosterone system (RAAS) inhibitors as the standard of care have scarcely met their primary endpoints until recently. This sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia Sanchez, Juan Jose, Thompson, Juliette, Scott, David A., Evans, Rachel, Rao, Naveen, Sörstadius, Elisabeth, James, Glen, Nolan, Stephen, Wittbrodt, Eric T., Abdul Sultan, Alyshah, Stefansson, Bergur V., Jackson, Dan, Abrams, Keith R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799552/ https://www.ncbi.nlm.nih.gov/pubmed/34881414 http://dx.doi.org/10.1007/s12325-021-02006-z

Ejemplares similares

Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review
por: Murton, Molly, et al.
Publicado: (2020)

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review
por: Darlington, Oliver, et al.
Publicado: (2021)

Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review
por: Cooper, Jacie T., et al.
Publicado: (2020)

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
por: Stefánsson, Bergur V., et al.
Publicado: (2011)

Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus
por: Go, Alan S., et al.
Publicado: (2018)

Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
por: Roughley, Matthew, et al.
Publicado: (2018)

Hemodiafiltration Improves Plasma 25-Hepcidin Levels: A Prospective, Randomized, Blinded, Cross-Over Study Comparing Hemodialysis and Hemodiafiltration
por: Stefánsson, Bergur V., et al.
Publicado: (2012)

Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective
por: de Pouvourville, Gérard, et al.
Publicado: (2023)

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers
por: Idzerda, Nienke M A, et al.
Publicado: (2019)

The Incidence of First Venous Thromboembolism in and around Pregnancy Using Linked Primary and Secondary Care Data: A Population Based Cohort Study from England and Comparative Meta-Analysis
por: Abdul Sultan, Alyshah, et al.
Publicado: (2013)

Comorbidities in polymyalgia rheumatica: a systematic review
por: Partington, Richard, et al.
Publicado: (2018)

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
por: Dekkers, Claire C J, et al.
Publicado: (2018)

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
por: Dekkers, Claire C J, et al.
Publicado: (2018)

Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
por: Cea Soriano, Lucia, et al.
Publicado: (2015)

Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study
por: Sultan, Alyshah Abdul, et al.
Publicado: (2019)

Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study
por: Fitzpatrick, Jesse K, et al.
Publicado: (2022)

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
por: Fioretto, Paola, et al.
Publicado: (2016)

Gout and subsequent erectile dysfunction: a population-based cohort study from England
por: Abdul Sultan, Alyshah, et al.
Publicado: (2017)

Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions
por: Johansson, Susanne, et al.
Publicado: (2017)

Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis
por: Abdul Sultan, Alyshah, et al.
Publicado: (2015)

Contemporary outcomes of anemia in US patients with chronic kidney disease
por: Wittbrodt, Eric T, et al.
Publicado: (2021)

Tenapanor administration and the activity of the H(+)‐coupled transporter PepT1 in healthy volunteers
por: Johansson, Susanne, et al.
Publicado: (2017)

Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England
por: Abdul Sultan, Alyshah, et al.
Publicado: (2013)

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
por: Heerspink, Hiddo J L, et al.
Publicado: (2020)

Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study
por: James, Glen, et al.
Publicado: (2020)

The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications
por: Rydén, Anna, et al.
Publicado: (2016)

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study
por: Paskins, Zoe, et al.
Publicado: (2018)

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis
por: McEwan, Phil, et al.
Publicado: (2022)

A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients
por: Cabrera, Claudia, et al.
Publicado: (2015)

Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study
por: Abdul Sultan, Alyshah, et al.
Publicado: (2015)

Incidence and sociodemographic characteristics of eczema diagnosis in children: A cohort study
por: Ban, Lu, et al.
Publicado: (2018)

Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population‐Based Cohort Study From England
por: Ban, Lu, et al.
Publicado: (2017)

Commissioning simulations to test new healthcare facilities: a proactive and innovative approach to healthcare system safety
por: Kaba, Alyshah, et al.
Publicado: (2019)

Methods and rationale of the DISCOVER CKD global observational study
por: Pecoits-Filho, Roberto, et al.
Publicado: (2021)

Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
por: Clarson, Lorna Elise, et al.
Publicado: (2020)

The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
por: Provenzano, Michele, et al.
Publicado: (2021)

Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts
por: Pöhlmann, Johannes, et al.
Publicado: (2022)

Qualitative Examination of Shared Decision-Making in Canada’s Largest Health System: More Work to be Done : Shared Decision-Making—More Work to be Done
por: Guirguis, Micheal, et al.
Publicado: (2021)

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
por: Heerspink, Hiddo J L, et al.
Publicado: (2021)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p98iii22v2u1bq25t8o6gef2tb